Master Alliance Provisions Guide (MAPGuide)

CureVac – European Commission COVID-19 Vaccine Advance Purchase Agreement

  • IP ownership & licensing | Exploitation of results
  • IP ownership & licensing | Ownership of results

Section I.20 Exploitation of the Results of the APA

I.20.1. The Parties acknowledge and agree that the contractor shall be the sole owner of all intellectual property rights generated during the development, manufacture, and supply of the Product, including all know-how (collectively, the “Product IP Rights”). The contractor shall be entitled to exclusively exploit any such Product IP Rights. Except as expressly set forth in this APA, the contractor does not grant to the Commission and/or the participating Member States by implication, estoppel or otherwise, any right, title, licence or interest in the Product IP Rights. 

I.20.2. All rights not expressly granted by the contractor hereunder are reserved by the contractor.